Pathos AI, Inc.
Biotechnology company · Chicago, Illinois, United States
Pathos AI, Inc. is a biotechnology company headquartered in Chicago, Illinois, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $283 million sold in a notice filed in 2025.
Pathos AI at a glance
What does Pathos AI do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $283 million sold (2025).
Frequently asked questions about Pathos AI
Where is Pathos AI headquartered?
Pathos AI, Inc. is headquartered in Chicago, Illinois, United States.
What does Pathos AI do?
Pathos AI, Inc. is a biotechnology company.
When was Pathos AI founded?
The earliest incorporation on record for Pathos AI, Inc. is in 2020, according to public company registers.
Similar companies
- Metame Health Inc.Chicago, Illinois, United States
- Synapticure, Inc.Chicago, Illinois, United States
- BiomeSense, Inc.Chicago, Illinois, United States
- Inomagen Therapeutics, Inc.Chicago, Illinois, United States
- Nuago Therapeutics, Inc.Chicago, Illinois, United States
- Advanced Cooling Therapy, Inc.Chicago, Illinois, United States
- Diagnostic Photonics, Inc.Chicago, Illinois, United States
- Microsensor Labs, LLCChicago, Illinois, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences